Clover Health Investments Corp [NASDAQ: CLOV] gained 10237394% on the last trading session, reaching $5890000.0 price per share at the time.
Clover Health Investments Corp represents 388.51 million in outstanding shares, while the company has a total market value of $1.44 billion with the latest information. CLOV stock price has been found in the range of $2.78 to $2.98.
If compared to the average trading volume of 5.89M shares, CLOV reached a trading volume of 10237394 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Clover Health Investments Corp [CLOV]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CLOV shares is $4.69 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CLOV stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Craig Hallum have made an estimate for Clover Health Investments Corp shares, keeping their opinion on the stock as Buy, with their previous recommendation back on December 17, 2024. While these analysts kept the previous recommendation, UBS raised their target price to Neutral. The new note on the price target was released on October 07, 2024, representing the official price target for Clover Health Investments Corp stock. Previously, the target price had yet another drop from $7 to $3, while Cowen kept a Market Perform rating on CLOV stock.
Trading performance analysis for CLOV stock
Clover Health Investments Corp [CLOV] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.91. With this latest performance, CLOV shares dropped by -19.60% in over the last four-week period, additionally sinking by -11.84% over the last 6 months – not to mention a drop of -10.16% in the past year of trading.
Clover Health Investments Corp [CLOV]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Clover Health Investments Corp [CLOV] shares currently have an operating margin of -1.64%. Clover Health Investments Corp’s Net Margin is presently recorded at -1.69%.
Return on Equity for this stock declined to -3.88%, with Return on Assets sitting at -3.88%.
An analysis of Institutional ownership at Clover Health Investments Corp [CLOV]
There are presently around $26.16%, or 27.22%% of CLOV stock, in the hands of institutional investors. The top three institutional holders of CLOV stocks are: VANGUARD GROUP INC with ownership of 17.35 million shares, which is approximately 3.5581%. RENAISSANCE TECHNOLOGIES LLC, holding 11.27 million shares of the stock with an approximate value of $$13.86 million in CLOV stocks shares; and RENAISSANCE TECHNOLOGIES LLC, currently with $$11.73 million in CLOV stock with ownership which is approximately 1.9568%.
